DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol

This trial was registered with the Australian and New Zealand Cancer Trials Registry on 13th Dec 2023, ACTRN12623001301651.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2024-11-08
DOI
https://doi.org/10.1186/s12885-024-13122-8
Citations
3
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
1.26
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol

Mark Nalder, Matthew Burge, Joanne M. Bowen, Rodney J. Scott et al.
3 citations
BMC Cancer
Lung Cancer Treatments and Mutations
1.26
article

DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol

Mark Nalder, Matthew Burge, Joanne M. Bowen, Rodney J. Scott, Christopher Oldmeadow, Janet K. Coller, Stephen P. Ackland, Cassandra White, Laura C. Edney, Hannah R. Wardill, Daniel Barker, Anne Thomas, Cheri Ostroff, Christos S. Karapetis, Adnan Nagrial, Lorraine A. Chantrill, Stephen John Clarke, Christine Paul, Matthew David Carlson, Timothy Price, Bruce Cheek, Trumaine Rankmore
article en
3 citations

Abstract

This trial was registered with the Australian and New Zealand Cancer Trials Registry on 13th Dec 2023, ACTRN12623001301651.

BMC CancerVol. 24(1)
University of Technology Sydney (AU), The University of Queensland (AU), Flinders University (AU), University of South Australia (AU), University of Wollongong (AU), Royal Brisbane and Women's Hospital (AU), John Hunter Hospital (AU), Flinders Medical Centre (AU), Cancer Australia (AU), Hunter Medical Research Institute (AU), Cooperative Trials Group for Neuro-Oncology (AU), Illawarra Shoalhaven Local Health District (AU), Queen Elizabeth Hospital (AU), Northern Sydney Local Health District (AU), Adelaide Institute for Sleep Health (AU), Westmead Institute (AU), South Australian Health and Medical Research Institute (AU), Sydney Local Health District (AU), The University of Adelaide (AU), University of Newcastle Australia (AU)
Good health and well-being
Openalex Percentile: Top 18%
Lung Cancer Treatments and Mutations
1.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.